A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.
Clinical trial NCT06270225 · UNKNOWN
Trial details
- NCT number
- NCT06270225
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-30
- Primary completion
- 2024-10-01
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.